sponsors

Nomura Code is a leading European investment banking team focused on Healthcare, Cleantech and Technology, and provides a full range of advisory, fundraising and broking services.

1 Carey Lane
London, EC2V 8AE
Tel: +44 (0)20 7776 1200
Fax: +44 (0)20 7776 1201
www.nomuracode.com

Nomura Code

Nomura Code is a full service investment bank providing expertise to small and medium sized companies in three sectors of industry: Healthcare, Clean Technology and Technology. Nomura Code is a wholly owned autonomous subsidiary of Nomura Europe Holdings and benefits from its parent's multinational presence and its larger company capabilities.

The business of Nomura Code was set up in 2003 from the successful Healthcare team at WestLB Panmure and was acquired by the Nomura Group in 2005.

Nomura Code's team of thirty professionals offers sector-specific services in Corporate Finance, Research, Institutional Sales and Market Making. Focussing on just three industry sectors allows Nomura Code to provide an in-depth knowledge and understanding of its clients' businesses.

Since 2003 Nomura Code has used this industry expertise to raise over €1.4bn for its corporate clients.

One of the UK's leading and most experienced financial communications consultancies.

107 Cheapside
London
EC2V 6DN
Tel: +44 (0) 20 7465 5000
Fax: +44 (0) 20 7465 5001
www.buchanan.uk.com

Buchanan is part of WPP, the world's largest advertising and communications group, which gives us unmatched international reach.

Buchanan Communications

Buchanan Communications has sponsored the Chief Executive of the Year Award since the inception of the Mediscience dinner 10 years ago. Our involvement reflects Buchanan's commitment to the healthcare sector, in which we have been a leading player for more than 20 years. By sponsoring this award, we are acknowledging the key role that Chief Executives play in a sector that for us has been so stimulating, rewarding, and at times challenging.

We have an exciting international client portfolio, which ranges from highly profitable pharmaceutical and services businesses through to innovative drug discoverers. Our clients are either publicly listed, in London or internationally or private where we support fund raisings, business development and trade sales.

A deep-rooted knowledge of the healthcare industry is the key to our successful relationships with clients and sector commentators. The Buchanan team brings long-term experience of proactive advisory support, IPOs, M&A, fund raisings and, when required, issues management.

Buchanan is part of WPP, the world's largest advertising and communications group, which gives us unmatched international reach.

College Hill Life Sciences provides a full service communications consultancy focused on science-based sectors.

The Registry
Royal Mint Court
London EC3N 4QN
Tel: +44 (0) 20 7457 2020
Fax: +44 (0) 20 74866 7900
www.college-lifesciences.com

College Hill

College Hill is a leading international business communications agency with an exceptionally strong focus in the Mediscience sector.

Its Life Sciences team is unique in that it has expertise across financial, corporate, healthcare and marketing communications, and integrates design into its communications mix.

College Hill Life Sciences also offers seamless global outreach with teams located in the UK, Germany, Australia and the US. It can tailor its programs to support organisations at all stages of development and has experience from start-ups to leading multi-national corporations, both private and public. Its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit and academic organisations and science-associated bodies.

One of the UK's leading, integrated corporate communications consultancies, with offices in London, Leeds, Cambridge, Edinburgh and Miami.

7 Ensign House
Admirals Way
London EC14 9XQ
Tel: +44 (0) 20 7536 2000
Fax: +44 (0) 20 7536 2001
www.design-portfolio.co.uk

The Design Portfolio Marketing Services is part of the flathill communications group plc.

Design Portfolio Marketing Services

Established in 1991, The Design Portfolio Marketing Services has developed into one of Europe's leading Corporate Communications consultancies. It works with over 130 quoted company clients, assisting them with their communication strategies, developing key messages and helping them build long term relationships with shareholders and potential shareholders. Key areas of expertise include designing and producing annual reports (both printed and online), analyst presentations, corporate and IR websites, corporate responsibility communications, internal communications and external communications such as webcasting and audiocasting. All of these services are available from our network of offices throughout the UK.

We work closely with a number of clients in the mediscience sector, where good communication and value for money are more important than ever.

The Design Portfolio Marketing Services is part of the flathill communications group plc.

Congratulations to all the nominees – we wish you all the best of luck tonight and continued success in the future.

For further information: www.design-portfolio.co.uk

Kempen & Co

Kempen & Co N.V. (Kempen & Co) is an international merchant bank with headquarters in Amsterdam and offices in New York and Edinburgh. Kempen & Co Corporate Finance B.V., a fully owned subsidiary of Kempen & Co, focuses on providing advice on mergers and acquisitions as well as capital market transactions. Clients include both listed and non-listed Pan-European companies. We focus on five specializations: life sciences and healthcare, real estate, utilities, renewables and cleantech, construction, maritime and offshore and financial institutions.

Kempen & Co Securities focuses on securities brokerage, with special emphasis on life sciences and Healthcare companies in Europe, publicly quoted real estate companies in Europe, and Dutch equities and derivatives, serving professional investors in primarily Europe and the US. Kempen & Co Securities provides clients with high-quality research and order execution.

For further information: www.kempen.com

M:Communications is an international firm advising on corporate reputation, M&A and financial market communications

01 Ropemaker Street
34th Floor
London EC2Y 9AW
Tel: +44 (0) 20 7920 2330
info@mcomgroup.com
www.mcomgroup.com

M:Communications

M:Communications was founded in 2002 and has quickly become Europe's most sought after financial and corporate communications agency. M:, with a global network of offices in London, New York, Dubai, Moscow and Hong Kong, represents some of the world's most successful international businesses and in particular, in Europe, has served or is retained by 60 of the EURO300. M:'s highly experienced senior consultants advise clients across a whole range of corporate and financial communications including reputation management, profile raising, media management, transactions, investor relations and crisis response.

M:'s sector specialist healthcare team has extensive experience across all sub-sectors of the industry and from leading agencies. The team is highly experienced in working alongside international healthcare clients, both public and private. M: prides itself on providing a high quality and proactive approach to clients and has quickly become established as a leading strategic healthcare communications and investor relations advisor.

The healthcare team at M: is pleased to be sponsoring this year's European Mediscience Awards Dinner and we hope you enjoy the evening.

For more information please visit www.mcomgroup.com, call us on +44 207 920 2345 or send an e-mail to healthcare@mcomgroup.com.

NASDAQ OMX is one global exchange dedicated to helping those who dream it, do it. Every day, we give the world's most innovative ideas the most innovative means of execution.

165 Broadway
New York, NY 10006
Tel: +1 212 401 87000
www.nasdaqomx.com

The NASDAQ OMX Group Inc.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius.

For more information about NASDAQ OMX, visit www.nasdaqomx.com.

Peel Hunt is a full-service broking house, entirely focussed on UK mid and small caps with the largest trading platform in the field.

111 Old Broad Street
London EC2N 1PH
Tel: +44 (0) 20 7418 8900
Fax: +44 (0) 20 7418 8848
info@peelhunt.com
www.peelhunt.com

Peel Hunt

Peel Hunt is an independent, full-service broking house with a focus on UK mid and small cap companies. Peel Hunt's management and employees recently completed a buyout from KBC and the firm's partnership structure, long-term profitability, extensive trading platform and focus on long-term client relationships, sets us apart from many of our peers.

We have expertise across a broad range of sectors and seek to offer high quality advice, ideas-led research and flawless execution within a team based, collegiate environment which reflects our partnership structure. We have raised over £2.3 billion for our clients since 2007 and continue to execute high quality equity and M&A transactions for our clients.

Our healthcare and life sciences team has witnessed considerable successes in recent months building on the credibility of our research and specialist sales teams, as well as the addition of a specialist corporate team in late 2009. Today our team comprises of Dr Paul Cuddon and Dr Stefan Hamill in research, Dr Ceri Morgan in specialist sales and James Steel and Dr Vijay Barathan in corporate who together have more than 50 years of experience within the sector. The high regard that both quoted companies and institutional investors have for our research and overall commitment to the healthcare and life sciences sector is highlighted by the client wins achieved by this team in recent months. We represent companies in the sector with an aggregate market capitalisation of some £1.5 billion, putting us firmly on track to becoming the leading mid market healthcare and life sciences firm in the City of London.

www.peelhunt.com

Peel Hunt LLP is authorised and regulated by the Financial Services Authority.